ALKYLAMINE.NS ALKYLAMINE NSE
₹1,651.30
-15.68% 1Y
Market & Price
Market Cap
-
Current Price
₹1,651.30
High / Low (52W)
₹2,398.00 / ₹1,231.60
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
₹-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
14.57%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
₹8.86
EPS (TTM)
₹-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
₹1,895.41 Cr
Current Assets
₹672.75 Cr
Working Capital
₹456.90 Cr
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-2.50%
Profit 5Y
-7.67%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
No notable strengths flagged.
CONS
- Revenue declined at -2.5% CAGR over 5 years.
- Earnings shrank at -7.7% CAGR over 5 years.
- Trading 31.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 371.20 Cr | 386.05 Cr | 405.53 Cr | 354.00 Cr | 386.91 Cr |
| Cost of Revenue | 191.63 Cr | 208.93 Cr | 219.84 Cr | 184.50 Cr | 209.59 Cr |
| Gross Profit | 179.57 Cr | 177.12 Cr | 185.69 Cr | 169.50 Cr | 177.32 Cr |
| Operating Expenses | 126.83 Cr | 126.92 Cr | 127.01 Cr | 120.03 Cr | 124.52 Cr |
| Operating Income | 52.74 Cr | 50.20 Cr | 58.68 Cr | 49.47 Cr | 52.80 Cr |
| EBITDA | 77.27 Cr | 77.13 Cr | 84.53 Cr | 75.17 Cr | 78.96 Cr |
| Interest Expense | 29.00 L | 17.00 L | 30.00 L | 24.00 L | 29.00 L |
| Pretax Income | 59.05 Cr | 59.35 Cr | 66.34 Cr | 57.24 Cr | 60.78 Cr |
| Tax Provision | 15.29 Cr | 13.33 Cr | 16.90 Cr | 14.98 Cr | 15.41 Cr |
| Net Income | 43.76 Cr | 46.02 Cr | 49.44 Cr | 42.26 Cr | 45.37 Cr |
| Diluted EPS | 8.55 | 8.99 | 9.65 | 8.25 | 8.86 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1,656.89 Cr | 1,419.00 Cr | 1,571.82 Cr | 1,535.85 Cr |
| Cost of Revenue | - | 880.86 Cr | 788.26 Cr | 838.78 Cr | 819.30 Cr |
| Gross Profit | - | 776.03 Cr | 630.74 Cr | 733.04 Cr | 716.55 Cr |
| Operating Expenses | - | 472.44 Cr | 434.27 Cr | 513.19 Cr | 503.57 Cr |
| Operating Income | - | 303.59 Cr | 196.48 Cr | 219.85 Cr | 212.98 Cr |
| EBITDA | - | 356.46 Cr | 265.18 Cr | 320.89 Cr | 316.30 Cr |
| Interest Expense | - | 2.73 Cr | 3.79 Cr | 1.01 Cr | 1.17 Cr |
| Pretax Income | - | 308.56 Cr | 202.47 Cr | 248.64 Cr | 243.47 Cr |
| Tax Provision | - | 79.90 Cr | 53.59 Cr | 62.53 Cr | 63.47 Cr |
| Net Income | - | 228.66 Cr | 148.87 Cr | 186.11 Cr | 180.00 Cr |
| Diluted EPS | - | 44.68 | 29.09 | 36.35 | 35.15 |
Compounded Sales Growth
| 5 Years: | -2.50% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -7.67% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -15.68% |
| 6 Months: | -3.66% |
| 3 Months: | +10.37% |
| 1 Month: | +8.92% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 1,591.91 Cr | 1,583.62 Cr | 1,788.86 Cr | 1,895.41 Cr |
| Current Assets | - | 500.64 Cr | 443.36 Cr | 630.12 Cr | 672.75 Cr |
| Cash & Equivalents | - | 17.19 Cr | 30.37 Cr | 48.78 Cr | 94.15 Cr |
| Inventory | - | 183.66 Cr | 171.97 Cr | 164.78 Cr | 122.13 Cr |
| Receivables | - | 258.42 Cr | 221.34 Cr | 230.15 Cr | 230.50 Cr |
| Total Liabilities | - | 422.99 Cr | 316.48 Cr | 386.37 Cr | 362.04 Cr |
| Current Liabilities | - | 354.17 Cr | 227.43 Cr | 245.16 Cr | 215.85 Cr |
| Long Term Debt | 0 | - | - | - | - |
| Total Debt | - | 87.75 Cr | 3.17 Cr | 5.53 Cr | 1.19 Cr |
| Total Equity | - | 1,168.93 Cr | 1,267.14 Cr | 1,402.48 Cr | 1,533.37 Cr |
| Shares Outstanding | - | 5.11 Cr | 5.11 Cr | 5.11 Cr | 5.11 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 248.38 Cr | 274.79 Cr | 263.10 Cr | 238.55 Cr |
| Investing Cash Flow | - | -277.05 Cr | -121.47 Cr | -195.54 Cr | -137.09 Cr |
| Financing Cash Flow | - | 7.99 Cr | -140.14 Cr | -49.15 Cr | -56.09 Cr |
| Capital Expenditure | - | -303.43 Cr | -122.32 Cr | -47.69 Cr | -128.41 Cr |
| Free Cash Flow | - | -55.04 Cr | 152.47 Cr | 215.41 Cr | 110.14 Cr |
| Net Change in Cash | - | -20.68 Cr | 13.19 Cr | 18.41 Cr | 45.37 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 46.8% | 44.4% | 46.6% | 46.7% |
| Operating Margin % | - | 18.3% | 13.8% | 14.0% | 13.9% |
| Net Margin % | - | 13.8% | 10.5% | 11.8% | 11.7% |
| ROE % | - | 19.6% | 11.7% | 13.3% | 11.7% |
| ROCE % | - | 24.5% | 14.5% | 14.2% | 12.7% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ALKYLAMINE
No recent headlines available.